May 9 (Reuters) - Indivior PLC INDV.L :
* LICENSING OF PERSERIS IN CANADA
* ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH HLS THERAPEUTICS FOR PERSERIS IN CANADA
* UNDER TERMS OF AGREEMENT, INDIVIOR HAS GRANTED AN EXCLUSIVE LICENSE TO HLS TO FILE AND COMMERCIALIZE PERSERIS IN CANADA
* ENTERED LICENSE AGREEMENT WITH HLS THERAPEUTICS FOR EXCLUSIVE COMMERCIALIZATION RIGHTS TO PERSERIS IN CANADA
* WILL RECEIVE $1 MLN UPON SIGNING OF DEFINITIVE AGREEMENT
* UPON COMMERCIALIZATION IN TERRITORY, CO ALSO ELIGIBLE TO RECEIVE ESCALATING DOUBLE-DIGIT ROYALTIES BASED ON ANNUAL NET SALES
* WILL RECEIVE A NEAR-TERM PAYMENT OF $4 MLN CONTINGENT UPON ACHIEVING CERTAIN REGULATORY AND PRE-COMMERCIAL MILESTONES